Former FDA commissioners raise alarm over new vaccine policy

The US Food and Drug Administration’s new vaccine approval philosophy upends established regulatory practices and could put ...

Former FDA commissioners castigate plan to change vaccine approval standards

A dozen former FDA commissioner say proposed FDA vaccine approval changes could impact public health, innovation, and biotech costs. Read more here.

A dozen former FDA commissioners condemn plan to tighten vaccine approvals

In a New England Journal of Medicine article, the former FDA commissioners wrote they were “deeply concerned” by the top vaccine regulator’s approach to raising the bar for approvals.

Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for slowing Alzheimer’s — a disease with few treatment options.